Ptc Therapeutics, Inc 10-Q for FY2024 Q2
Ptc Therapeutics, Inc. (PTCT)
10-Q
2024-08-08
For: 2024-06-30
View Original
Added on
April 07, 2026
About this 10-Q
Ptc Therapeutics, Inc filed this 10-Q on August 8, 2024, covering the quarter ended June 30, 2024 (FY2024 Q2).
Headline figures
Quarter ended June 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $186.7M
- down 12.7% from $213.81M a year earlier
- Net loss
- $99.18M
- compared with a net loss of $198.88M a year earlier
- Diluted EPS
- -$1.29
- compared with -$2.66 a year earlier